Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;190(3):1111-1116.
doi: 10.1007/s11845-020-02396-z. Epub 2020 Oct 11.

Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae

Affiliations

Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae

Noel E Donlon et al. Ir J Med Sci. 2021 Aug.

Abstract

Chyle leakage from the thoracic duct or cisterna chyli is a relatively rare complication of oesophageal cancer surgery. The majority of cases settle with conservative measures, but high volume leaks may be refractory and result in significant morbidity and require intervention with reoperation or embolization. In the experience of this high-volume centre over the last decade, 3 (0.5%) patients required reoperation and ligation of the thoracic duct; for the so-called type III leaks, interventional radiological approaches were not considered. This article is built around two recent cases, where interventional radiology to embolize and disrupt complex fistulae was successfully performed. The lessons from this experience will change practice at this centre to initial lymphangiography with a view to embolization or disruption of thoracic duct and cisterna chyli leaks as first line therapy for type III chyle leaks, with surgery reserved for where this fails.

Keywords: Chyle leak; Medium-chain fatty acids; Oesophageal Cancer; Thoracic duct embolization; Thoracic duct ligation.

PubMed Disclaimer

References

    1. Lagarde SM, Omloo JM, de Jong K et al (2005) Incidence and management of chyle leakage after esophagectomy. Ann Thorac Surg 80(2):449–454 - DOI
    1. Miao L, Zhang Y, Hu H et al (2015) Incidence and management of chylothorax after esophagectomy. Thorac Cancer. 6(3):354–358 - DOI
    1. Kim D, Cho J, Kim K, Shim YM (2014) Chyle leakage patterns and management after oncologic esophagectomy: a retrospective cohort study. Thorac Cancer 5(5):391–397 - DOI
    1. Shah RD, Luketich JD, Schuchert MJ et al (2012) Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg 93(3):897–903 discussion −4 - DOI
    1. Phang K, Bowman M, Phillips A, Windsor J (2014) Review of thoracic duct anatomical variations and clinical implications. Clin Anat 27(4):637–644 - DOI

LinkOut - more resources